Skip to main content

Advertisement

Open Peer Review Reports for: AMPD1: a novel therapeutic target for reversing insulin resistance

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
7 Oct 2014 Submitted Original manuscript
7 Oct 2014 Author responded Author comments - Takayuki Morisaki
Resubmission - Version 2
7 Oct 2014 Submitted Manuscript version 2
8 Oct 2014 Author responded Author comments - Takayuki Morisaki
Resubmission - Version 3
8 Oct 2014 Submitted Manuscript version 3
6 Nov 2014 Reviewed Reviewer Report - Richard Sabina
10 Nov 2014 Reviewed Reviewer Report - Junichi Sadoshima
30 Nov 2014 Author responded Author comments - Takayuki Morisaki
Resubmission - Version 4
30 Nov 2014 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
1 Dec 2014 Author responded Author comments - Takayuki Morisaki
Resubmission - Version 6
1 Dec 2014 Submitted Manuscript version 6
Publishing
9 Dec 2014 Editorially accepted
15 Dec 2014 Article published 10.1186/1472-6823-14-96

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement